IQVIA Holdings Inc (IQV)vsInotiv Inc (NOTV)
IQV
IQVIA Holdings Inc
$261.77
+1.74%
HEALTHCARE · Cap: $42.24B
NOTV
Inotiv Inc
$0.01
-26.00%
HEALTHCARE · Cap: $5.79M
Smart Verdict
WallStSmart Research — data-driven comparison
IQVIA Holdings Inc generates 3247% more annual revenue ($16.98B vs $507.36M). IQV leads profitability with a 8.1% profit margin vs -17.1%. IQV earns a higher WallStSmart Score of 55/100 (C).
IQV
Buy55
out of 100
Grade: C
NOTV
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+11.9%
Fair Value
$201.21
Current Price
$261.77
$60.56 discount
Intrinsic value data unavailable for NOTV.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 22 in profit
Growing faster than its price suggests
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
Weak financial health signals
Earnings declined 0.6%
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -74.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : IQV
The strongest argument for IQV centers on Return on Equity, PEG Ratio. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bull Case : NOTV
The strongest argument for NOTV centers on Price/Book.
Bear Case : IQV
The primary concerns for IQV are P/E Ratio, Piotroski F-Score, EPS Growth. Debt-to-equity of 2.63 is elevated, increasing financial risk.
Bear Case : NOTV
The primary concerns for NOTV are EPS Growth, Market Cap, Piotroski F-Score. Debt-to-equity of 6.33 is elevated, increasing financial risk.
Key Dynamics to Monitor
IQV profiles as a value stock while NOTV is a turnaround play — different risk/reward profiles.
NOTV carries more volatility with a beta of 3.77 — expect wider price swings.
IQV is growing revenue faster at 8.7% — sustainability is the question.
IQV generates stronger free cash flow (360M), providing more financial flexibility.
Bottom Line
IQV scores higher overall (55/100 vs 31/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
IQVIA Holdings Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Inotiv Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?